Literature DB >> 8914675

Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease.

H Okada1, M Mizuno, K Yamamoto, T Tsuji.   

Abstract

To characterize primary sclerosing cholangitis (PSC) in Japanese patients and its association with inflammatory bowel disease (IBD), 155 reported cases of PSC, including 6 cases of our own, were reviewed. The prevalence of IBD was less in Japanese PSC patients than in Western patients (23% versus 62-100%). Japanese PSC patients with IBD were younger (mean age, 33.1 versus 51.8 years) and were more often women (51% versus 36%) than those without IBD. Seventy-four percent of PSC patients with IBD had extensive colonic lesions, and 89% of those developed IBD simultaneously, with or prior to PSC. There were 3 cases of neutrophilic cholangitis among the PSC patients with IBD but none in those without IBD. Based on these observations, we speculate that there may be subtypes of PSC which differ pathophysiologically.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914675     DOI: 10.18926/AMO/30499

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  4 in total

1.  Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India.

Authors:  Pratik Tibdewal; Pratin Bhatt; Abhinav Jain; Deepak Gupta; Shobna Bhatia; Akash Shukla
Journal:  Indian J Gastroenterol       Date:  2019-09-12

Review 2.  Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

Authors:  Rebecca Saich; Roger Chapman
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 3.  Role of the microbiota and antibiotics in primary sclerosing cholangitis.

Authors:  James H Tabibian; Jayant A Talwalkar; Keith D Lindor
Journal:  Biomed Res Int       Date:  2013-10-22       Impact factor: 3.411

4.  Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom.

Authors:  Huifang Liang; Sudhakar Manne; Jesse Shick; Trevor Lissoos; Paul Dolin
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.